MOODE®

- Depression is the leading cause of incapacity in the world.

- It affects more than 350 million people worldwide with a higher incidence in women.

- In Portugal, it is estimated that the prevalence of depressive disorders throughout the entire life can be up to 18%.

- The prevalence of depression has been associated with changes in the diet, mostly regarding the level of ingestion of foods rich in essential fatty acids such as omega-3.

MOODE®

Development of a supporting product to antidepressant therapy.

Through the balance between essential fatty acids, physical, psychic, and behavioral improvements can be achieved.

MOODE®

Supplementation with 1 g of eicosapentaenoic acid (EPA), combined with antidepressant therapy, has improved the symptoms of depression in patients diagnosed with depressive disorders.

MOODE®

Support for antidepressant therapy.

MOODE®

Presentation: pack of 60 capsules.

CNP: 6052076

MOODE®

Take 1 or 2 capsules a day, at the main courses, or according to the recommendation received.

Recommended duration of use: throughout the duration of antidepressant therapy.

MOODE®

Due to the lack of studies confirming the safety of use in case of pregnancy and breastfeeding, this supplement should not be used in these situations, unless indicated otherwise by your doctor or pharmacist.

The product should not be used in case of hypersensitivity, allergy and when there are known interactions between any ingredient of this formulation and other products.

Caution is advised when taking this product having coagulation disorders, your doctor or pharmacist should be consulted.

Let your doctor know that you are taking this food supplement if you are going to be submitted to surgery. It may be necessary to interrupt the supplement intake.